Can Pityriasis rosea be transmitted to newborns and what precautions should be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Pityriasis rosea is not considered contagious to newborns, and no special precautions are typically needed if a mother or caregiver has this condition. Pityriasis rosea is a benign, self-limiting skin rash that is not believed to be highly contagious through normal contact. While the exact cause remains unclear, it may be associated with human herpesvirus 6 or 7, but direct person-to-person transmission is rarely documented 1. For mothers with pityriasis rosea, standard hygiene practices like handwashing before handling the baby are sufficient. The condition typically resolves on its own within 6-12 weeks without specific treatment. No isolation or special barriers are required when caring for a newborn. If the rash is particularly uncomfortable, treatments like topical corticosteroids, antihistamines, or UVB phototherapy may be used, but these are for symptom management and don't affect potential transmission.

Some key points to consider:

  • Pityriasis rosea is a common, acute exanthem of uncertain etiology, but it is thought to be associated with human herpesvirus 6 or 7 2.
  • The condition is characterized by a herald patch, followed by a generalized rash, and can be accompanied by systemic symptoms such as fever, headache, and fatigue 3.
  • Pityriasis rosea during pregnancy has been linked to spontaneous abortions, particularly if the condition occurs during the first 15 gestational weeks 3.
  • Treatment options for pityriasis rosea include acyclovir, ultraviolet phototherapy, and symptomatic relief with topical corticosteroids or antihistamines 4, 5.
  • L-lysine therapy has been reported to be effective in controlling the clinical evolution of pityriasis rosea, although more research is needed to confirm its efficacy 4.

It's essential to note that while pityriasis rosea is not typically contagious, pregnant women with the condition should be closely monitored due to the potential risks associated with the condition during pregnancy. If you're concerned about your specific situation, consulting with your healthcare provider can provide personalized guidance based on your circumstances and the severity of your condition.

References

Research

Pityriasis Rosea: An Updated Review.

Current pediatric reviews, 2021

Research

Pityriasis rosea.

American family physician, 2004

Research

Pityriasis Rosea: Diagnosis and Treatment.

American family physician, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.